Volume 23, Number 11—November 2017
Dispatch
Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru
Table 1
Resistance† | Simple, no. (%) | Clonal, no. (%) | Polyclonal, no. (%) |
---|---|---|---|
Pansensitive | 1,917 (67.9) | 73 (63.5) | 88 (54.7) |
INH or RIF resistance | 260 (9.2) | 11 (9.6) | 17 (10.6) |
Multidrug | 333 (11.8) | 15 (13.0) | 27 (16.8) |
Other |
312 (11.1) |
16 (13.9) |
29 (18.0) |
Total | 2,822 | 115 | 161 |
*Mycobacterium tuberculosis strain type determined by classifier of tandem repeats. INH, isoniazid; RIF, rifampin; TB, tuberculosis.
†Drug susceptibility testing was performed for RIF, INH, streptomycin, ethambutol, and pyrazinamide.
1These authors contributed equally to this article.
Page created: October 17, 2017
Page updated: October 17, 2017
Page reviewed: October 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.